27 results
DEF 14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Definitive proxy
8:24am
L’Oreal, Dr. Spenlehauer served as Head of Pharmaceutical Sciences for Pfizer’s R&D operations in the UK. He began his career as a Scientist at Rhone
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
L’Oreal, Dr. Spenlehauer served as Head of Pharmaceutical Sciences for Pfizer’s R&D operations in the UK. He began his career as a Scientist at Rhone
8-K
EX-99.1
ol4we27b6zg zwn0v1df
1 Apr 24
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
4:47pm
8-K
EX-99.1
1oxlv955
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-99.1
94fb59plbggiec
16 Jan 24
Carmell Corp Announces Addition of Dr. Bradley Calobrace to Scientific Advisory Board
7:27pm
8-K
EX-99.1
mcqhmpc p1bd
16 Jan 24
Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board
7:14pm
8-K
EX-99.1
1tlxp45gwivx58citt
16 Jan 24
Carmell Corp Announces Addition of Dr. Gregory A. Buford to Scientific Advisory Board
7:07pm
8-K/A
EX-99.1
ikjl79d379r
16 Jan 24
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
7:06pm
8-K/A
EX-99.1
zhvzx7aw 1n0asj8b
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:51pm
8-K
EX-99.1
tsz9k951ensc1coqk
16 Jan 24
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
6:06pm
8-K
EX-99.1
ckerfk94b0vdrcf6
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:01pm
8-K
EX-99.1
6oux4usa
15 Nov 23
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
9:54pm
8-K
3v3wkifdsrx42jy
15 Nov 23
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
9:54pm
8-K
EX-99.1
sc5kh kiv7k
6 Sep 23
Departure of Directors or Certain Officers
4:18pm
8-K
EX-99.2
skf hrqg23n46cscdk1
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
425
q60m5d7u
6 Jul 23
Business combination disclosure
5:15pm